ALB and hepatorenal syndrome: Terlipressin improved renal function and reversed Hepatorenal syndrome in a higher proportion of patients with Hepatorenal syndrome type 1 and Systemic Inflammatory Response Syndrome (SIRS) than patients who received albumin plus placebo.